Rafferty Asset Management’s Sage Therapeutics SAGE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-149,114	Closed	-$1.08M	–	1171
2024 Q3	$1.08M	Buy	149,114 +25,855	+21%	+$237K	﹤0.01%	786
2024 Q2	$1.34M	Sell	123,259 -269,166	-69%	-$3.45M	0.01%	749
2024 Q1	$7.35M	Buy	392,425 +85,511	+28%	+$1.97M	0.03%	369
2023 Q4	$6.65M	Sell	306,914 -104,990	-25%	-$2.08M	0.03%	382
2023 Q3	$8.48M	Buy	411,904 +273,257	+197%	+$7.89M	0.05%	266
2023 Q2	$6.52M	Sell	138,647 -27,084	-16%	-$1.35M	0.04%	356
2023 Q1	$6.95M	Buy	165,731 +1,874	+1%	+$80.6K	0.05%	296
2022 Q4	$6.25M	Sell	163,857 -1,096	-0.7%	-$41.9K	0.05%	326
2022 Q3	$6.46M	Buy	164,953 +67,491	+69%	+$2.61M	0.07%	256
2022 Q2	$3.15M	Sell	97,462 -77,086	-44%	-$2.58M	0.03%	380
2022 Q1	$5.78M	Buy	174,548 +35,792	+26%	+$1.35M	0.03%	345
2021 Q4	$5.9M	Buy	138,756 +65,963	+91%	+$2.76M	0.03%	310
2021 Q3	$3.23M	Buy	72,793 +39,819	+121%	+$1.83M	0.02%	436
2021 Q2	$1.87M	Sell	32,974 -9,354	-22%	-$661K	0.01%	705
2021 Q1	$3.17M	Buy	42,328 +28,826	+213%	+$2.36M	0.02%	454
2020 Q4	$1.17M	Sell	13,502 -22,101	-62%	-$1.63M	0.01%	471
2020 Q3	$2.18M	Buy	35,603 +9,224	+35%	+$467K	0.03%	393
2020 Q2	$1.1M	Buy	+26,379	New	+$957K	0.02%	517
2020 Q1	–	Sell	-53,837	Closed	-$3.89M	–	768
2019 Q4	$3.89M	Buy	53,837 +13,276	+33%	+$1.63M	0.06%	169
2019 Q3	$5.69M	Buy	40,561 +12,189	+43%	+$2.04M	0.09%	138
2019 Q2	$5.2M	Sell	28,372 -4,492	-14%	-$766K	0.09%	155
2019 Q1	$5.23M	Buy	+32,864	New	+$4.76M	0.08%	132

Other funds holding SAGE